Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic Syndrome-Reference-Cited by-同舟云学术

Antihypertensive Efficacy and Safety of Olmesartan Medoxomil and Ramipril in Elderly Mild to Moderate Essential Hypertensive Patients With or Without Metabolic Syndrome

Published:2012-11-16 Issue:12 Volume:29 Page:981-992
ISSN:1170-229X
Container-title:Drugs & Aging
language:en
Short-container-title:Drugs Aging

Author:

Omboni Stefano,Malacco Ettore,Mallion Jean-Michel,Volpe Massimo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Geriatrics and Gerontology

Link

http://link.springer.com/content/pdf/10.1007/s40266-012-0030-3.pdf

Reference45 articles.

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28.

2. Hu G, Qiao Q, Tuomilehto J, DECODE Study Group, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med. 2004;164:1066–76.

3. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745–9.

4. Mannucci E, Monami M, Bardini G, et al. National Cholesterol Educational Program and International Diabetes Federation diagnostic criteria for metabolic syndrome in an Italian cohort: results from the FIBAR Study. J Endocrinol Invest. 2007;30:925–30.

5. Rueda Alfaro S, Serra-Prat M, Fernández Fernández C, et al. Estudio de Envejecimiento de Mataró. Metabolic syndrome and cardiovascular disease in elders: results of the Mataró Ageing study. Med Clin (Barc). 2008;130:327–31.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients;High Blood Pressure & Cardiovascular Prevention;2021-03-12

2. Personalised Single-Pill Combination Therapy in Hypertensive Patients: An Update of a Practical Treatment Platform;High Blood Pressure & Cardiovascular Prevention;2017-10-31

3. Management of Hypertension Using Olmesartan Alone or in Combination;Cardiology and Therapy;2017-03-03

4. Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome);Journal of Hypertension;2016-11

5. Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines;Clinical Interventions in Aging;2015-10